High-Density lipoproteins decrease proinflammatory activity and modulate the innate immune response
Atherosclerosis, a chronic inflammatory disease of the arterial wall, is the leading cause of cardiac disorders and stroke. The onset and progression of these diseases are linked with the inflammatory response, especially NLRP3 inflammasome activation, inducing the production of proinflammatory cyto...
- Autores:
-
Taborda, Natalia Andrea
Blanquiceth, Yurany
Urcuqui Inchima, Silvio
Latz, Eicke
Hernández López, Juan Carlos
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2019
- Institución:
- Universidad Cooperativa de Colombia
- Repositorio:
- Repositorio UCC
- Idioma:
- OAI Identifier:
- oai:repository.ucc.edu.co:20.500.12494/28300
- Acceso en línea:
- https://hdl.handle.net/20.500.12494/28300
- Palabra clave:
- Atherosclerosis
- Rights
- openAccess
- License
- Atribución
| id |
COOPER2_eccab4111ecad7c9ebe39b3ef0186699 |
|---|---|
| oai_identifier_str |
oai:repository.ucc.edu.co:20.500.12494/28300 |
| network_acronym_str |
COOPER2 |
| network_name_str |
Repositorio UCC |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
High-Density lipoproteins decrease proinflammatory activity and modulate the innate immune response |
| title |
High-Density lipoproteins decrease proinflammatory activity and modulate the innate immune response |
| spellingShingle |
High-Density lipoproteins decrease proinflammatory activity and modulate the innate immune response Atherosclerosis |
| title_short |
High-Density lipoproteins decrease proinflammatory activity and modulate the innate immune response |
| title_full |
High-Density lipoproteins decrease proinflammatory activity and modulate the innate immune response |
| title_fullStr |
High-Density lipoproteins decrease proinflammatory activity and modulate the innate immune response |
| title_full_unstemmed |
High-Density lipoproteins decrease proinflammatory activity and modulate the innate immune response |
| title_sort |
High-Density lipoproteins decrease proinflammatory activity and modulate the innate immune response |
| dc.creator.fl_str_mv |
Taborda, Natalia Andrea Blanquiceth, Yurany Urcuqui Inchima, Silvio Latz, Eicke Hernández López, Juan Carlos |
| dc.contributor.author.none.fl_str_mv |
Taborda, Natalia Andrea Blanquiceth, Yurany Urcuqui Inchima, Silvio Latz, Eicke Hernández López, Juan Carlos |
| dc.subject.spa.fl_str_mv |
Atherosclerosis |
| topic |
Atherosclerosis |
| description |
Atherosclerosis, a chronic inflammatory disease of the arterial wall, is the leading cause of cardiac disorders and stroke. The onset and progression of these diseases are linked with the inflammatory response, especially NLRP3 inflammasome activation, inducing the production of proinflammatory cytokines, such as interleukin 1b (IL-1b). Because high-density lipoproteins (HDLs) have shown significant antiatherogenic and antiinflammatory properties, we evaluated their immunomodulatory activity in response to cholesterol crystals and other innate immune activators. Human primary monocyte-derived macrophages, THP-1 cells, and murine macrophages were stimulated to activate NLRP3 inflammasome and other pattern recognition receptors, in the presence or absence of HDL. Then, HDL immunomodulatory effects were evaluated through IL-1b and IL-6 production by enzyme-linked immunosorbent assay. Furthermore, in vivo HDL antiinflammatory effects were evaluated in a murine model of peritoneal inflammatory infiltration. HDLs have an immunomodulatory effect on different cellular models, including peripheral blood mononuclear cells, THP-1 cells, and murine macrophages, by affecting the activity of innate immunity sensors, such as Toll-like receptors (TLRs), dectin-1, and inflammasomes. HDL reduces the proinflammatory role of cholesterol crystals, nigericin, and other NLRP3 and AIM2 inflammasome agonists, and several TLR agonists, leading to a decreased production of IL-1b and IL-6. The results suggest that HDLs are highly important in the regulation of the innate immune response and may have a beneficial role in controlling diseases associated with the inflammatory response. |
| publishDate |
2019 |
| dc.date.issued.none.fl_str_mv |
2019-12-01 |
| dc.date.accessioned.none.fl_str_mv |
2020-11-27T00:59:20Z |
| dc.date.available.none.fl_str_mv |
2020-11-27T00:59:20Z |
| dc.type.none.fl_str_mv |
Artículo |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
| dc.type.coarversion.none.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.version.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
http://purl.org/coar/resource_type/c_6501 |
| status_str |
publishedVersion |
| dc.identifier.uri.spa.fl_str_mv |
10.1089/jir.2019.0029 |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.12494/28300 |
| dc.identifier.bibliographicCitation.spa.fl_str_mv |
Taborda, N. A., Blanquiceth, Y., Urcuqui-Inchima, S., Latz, E., y Hernandez, J. C. (2019). High-Density Lipoproteins Decrease Proinflammatory Activity and Modulate the Innate Immune Response. Journal of Interferon & Cytokine Research, 39 (12), 760-770. Recuperado de https://www.liebertpub.com/doi/abs/10.1089/jir.2019.0029 |
| identifier_str_mv |
10.1089/jir.2019.0029 Taborda, N. A., Blanquiceth, Y., Urcuqui-Inchima, S., Latz, E., y Hernandez, J. C. (2019). High-Density Lipoproteins Decrease Proinflammatory Activity and Modulate the Innate Immune Response. Journal of Interferon & Cytokine Research, 39 (12), 760-770. Recuperado de https://www.liebertpub.com/doi/abs/10.1089/jir.2019.0029 |
| url |
https://hdl.handle.net/20.500.12494/28300 |
| dc.relation.isversionof.spa.fl_str_mv |
https://www.liebertpub.com/doi/abs/10.1089/jir.2019.0029 |
| dc.relation.ispartofjournal.spa.fl_str_mv |
Journal of Interferon & Cytokine Research |
| dc.relation.references.spa.fl_str_mv |
Barrientos-Arenas E, Henao-García V, Giraldo DM, Cardona MM, Urcuqui Inchima S, Castaño JC, Hernández JC. 2018. [Modulation of high-density lipoprotein and cytokine IL-1β and IL-6 levels in patients with dengue]. Rev Peru Med Exp Salud Publica 35(1):15-24. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V, Latz E. 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183(2):787-91 Beckman JA, Creager MA. 2006. The nonlipid effects of statins on endothelial function. Trends Cardiovasc Med 16(5):156-62. Beckman JA, Creager MA. 2006. The nonlipid effects of statins on endothelial function. Trends Cardiovasc Med 16(5):156-62. Cao J, Xu Y, Li F, Shang L, Fan D, Yu H. 2018. Protein markers of dysfunctional HDL in scavenger receptor class B type I deficient mice. J Transl Med 16(1):155. Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ. 1995. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 15(11):1987-94. Cook DN, Pisetsky DS, Schwartz DA. 2004. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5(10):975-9 Cuzzocrea S, Dugo L, Patel NS, Di Paola R, Cockerill GW, Genovese T, Thiemermann C. 2004. High-density lipoproteins reduce the intestinal damage associated with ischemia/reperfusion and colitis. Shock 21(4):342-51. Charles-Schoeman C, Gugiu GB, Ge H, Shahbazian A, Lee YY, Wang X, Furst DE, Ranganath VK, Maldonado M, Lee T, Reddy ST. 2018. Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritis. Atherosclerosis 275:107-114. Chinni SR, Yamamoto H, Dong Z, Sabbota A, Bonfil RD, Cher ML. 2008. CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone. Mol Cancer Res 6(3):446-57. de la Roche M, Hamilton C, Mortensen R, Jeyaprakash AA, Ghosh S, Anand PK. 2018. Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation. J Cell Biol De Nardo D, Labzin LI, Kono H, Seki R, Schmidt SV, Beyer M, Xu D, Zimmer S, Lahrmann C, Schildberg FA, Vogelhuber J, Kraut M, Ulas T, Kerksiek A, Krebs W, Bode N, Grebe A, Fitzgerald ML, Hernandez NJ, Williams BR, Knolle P, Kneilling M, Röcken M, Lütjohann D, Wright SD, Schultze JL, Latz E. 2014. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat Immunol 15(2):152-60. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nuñez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E. 2010. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464(7293):1357-61. Ebrahim S, Taylor FC, Brindle P. 2014. Statins for the primary prevention of cardiovascular disease. BMJ 348:g280 Galbois A, Thabut D, Tazi KA, Rudler M, Mohammadi MS, Bonnefont-Rousselot D, Bennani H, Bezeaud A, Tellier Z, Guichard C, Coant N, Ogier-Denis E,Moreau R, Lebrec D. 2009. Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis. Hepatology 49(1):175-84. Gilchrist M, Thorsson V, Li B, Rust AG, Korb M, Roach JC, Kennedy K, Hai T, Bolouri H, Aderem A. 2006. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441(7090):173-8. Grebe A, Latz E. 2013. Cholesterol crystals and inflammation. Curr Rheumatol Rep 15(3):313. Guo H, Callaway JB, Ting JP. 2015. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med 21(7):677-87. Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E, Halle A, Korte M, Latz E, Golenbock DT. 2013. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493(7434):674-8. Hernandez J, Sirois C, Latz E. 2011. Activation and Regulation of the NLRP3 Inflammasome. In.The Inflammasomes, Springer Basel. pp 197-208. Hernandez JC, Latz E, Urcuqui-Inchima S. 2014. HIV-1 induces the first signal to activate the NLRP3 inflammasome in monocyte-derived macrophages. Intervirology 57(1):36-42. Hernandez JC, Urcuqui-Inchima S. 2012. Activación y regulación del inflamasoma NLRP3 en las enfermedades infecciosas. Iatreia380-390. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9(8):847-56 Hornung V, Latz E. 2010. Critical functions of priming and lysosomal damage for 632 NLRP3 activation. Eur J Immunol 40(3):620-3. Inoue M, Williams KL, Gunn MD, Shinohara ML. 2012. NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 109(26):10480- 5. Kankkunen P, Teirilä L, Rintahaka J, Alenius H, Wolff H, Matikainen S. 2010. (1,3)-beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages. J Immunol 184(11):6335-42. Kant S, Kumar A, Singh SM. 2013. Myelopoietic efficacy of orlistat in murine hosts bearing T cell lymphoma: implication in macrophage differentiation and activation. PLoS One 8(12):e82396. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11(5):373-84. Kitchens RL, Wolfbauer G, Albers JJ, Munford RS. 1999. Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J Biol Chem 274(48):34116-22. Latz E, Xiao TS, Stutz A. 2013. Activation and regulation of the inflammasomes. Nat Rev Immunol 13(6):397-411. Lawrence T, Gilroy DW. 2007. Chronic inflammation: a failure of resolution? Int J Exp Pathol 88(2):85-94. Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL. 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci U S A 90(24):12040-4. Li WL, Hua LG, Qu P, Yan WH, Ming C, Jun YD, Yuan LD, Nan N. 2016. NLRP3 inflammasome: a novel link between lipoproteins and atherosclerosis. Arch Med Sci 12(5):950-958. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440(7081):228- 32. Marín-Palma D, Castro GA, Cardona-Arias JA, Urcuqui-Inchima S, Hernandez JC. 2018. Lower High-Density Lipoproteins Levels During Human Immunodeficiency Virus Type 1 Infection Are Associated With Increased Inflammatory Markers and Disease Progression. Front Immunol 9:1350. Martinon F, Gaide O, Pétrilli V, Mayor A, Tschopp J. 2007. NALP inflammasomes: a central role in innate immunity. Semin Immunopathol 29(3):213-29 Martinon F, Mayor A, Tschopp J. 2009. The inflammasomes: guardians of the 669 body. Annu Rev Immunol 27:229-65. McDonald MC, Dhadly P, Cockerill GW, Cuzzocrea S, Mota-Filipe H, Hinds CJ, Miller NE, Thiemermann C. 2003. Reconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shock. Shock 20(6):551-7. McGeough MD, Pena CA, Mueller JL, Pociask DA, Broderick L, Hoffman HM, Brydges SD. 2012. Cutting edge: IL-6 is a marker of inflammation with no direct role in inflammasome-mediated mouse models. J Immunol 189(6):2707-11. McGrath KC, Li XH, Puranik R, Liong EC, Tan JT, Dy VM, DiBartolo BA, Barter PJ, Rye KA, Heather AK. 2009. Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol 29(6):877- 82. Miljkovic M, Stefanovic A, Simic-Ogrizovic S, Vekic J, Bogavac-Stanojevic N, Cerne D, Kocbek P, Marc J, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Kotur-Stevuljevic J. 2018. Association of Dyslipidemia, Oxidative Stress, Juan C Hernandez 35 and Inflammation With Redox Status in VLDL, LDL, and HDL Lipoproteins in Patients With Renal Disease. Angiology:3319718780041. Mineo C, Yuhanna IS, Quon MJ, Shaul PW. 2003. High density lipoprotein induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem 278(11):9142-9. Muñoz-Planillo R, Kuffa P, Martínez-Colón G, Smith BL, Rajendiran TM, Núñez G. 2013. K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38(6):1142- 53. Niyonzima N, Samstad EO, Aune MH, Ryan L, Bakke SS, Rokstad AM, Wrigh SD, Damås JK, Mollnes TE, Latz E, Espevik T. 2015. Reconstituted High Density Lipoprotein Attenuates Cholesterol Crystal-Induced Inflammatory Responses by Reducing Complement Activation. J Immunol 195(1):257- 64. Norata GD, Pirillo A, Ammirati E, Catapano AL. 2012. Emerging role of high density lipoproteins as a player in the immune system. Atherosclerosis 220(1):11-21. Park SH, Park JH, Kang JS, Kang YH. 2003. Involvement of transcription factors in plasma HDL protection against TNF-alpha-induced vascular cell adhesion molecule-1 expression. Int J Biochem Cell Biol 35(2):168-82 Peeters PM, Eurlings IM, Perkins TN, Wouters EF, Schins RP, Borm PJ, Drommer W, Reynaert NL, Albrecht C. 2014. Silica-induced NLRP3 inflammasome activation in vitro and in rat lungs. Part Fibre Toxicol 11:58. Peshavariya H, Dusting GJ, Di Bartolo B, Rye KA, Barter PJ, Jiang F. 2009. Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts. Free Radic Res 43(8):772-82. Rajamäki K, Lappalainen J, Oörni K, Välimäki E, Matikainen S, Kovanen PT, Eklund KK. 2010. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One 5(7):e11765. Riwanto M, Rohrer L, Roschitzki B, Besler C, Mocharla P, Mueller M, Perisa D, Heinrich K, Altwegg L, von Eckardstein A, Lüscher TF, Landmesser U. 2013. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of Juan C Hernandez 36 high-density lipoprotein-proteome remodeling. Circulation 127(8):891- 904. Robbesyn F, Garcia V, Auge N, Vieira O, Frisach MF, Salvayre R, Negre Salvayre A. 2003. HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells. FASEB J 17(6):743-5. Robbins GR, Wen H, Ting JP. 2014. Inflammasomes and metabolic disorders: old genes in modern diseases. Mol Cell 54(2):297-308. Roberson SM, Walker WS. 1988. Immortalization of cloned mouse splenic macrophages with a retrovirus containing the v-raf/mil and v-myc oncogenes. Cell Immunol 116(2):341-51. Rosenson RS, Brewer HB, Ansell BJ, Barter P, Chapman MJ, Heinecke JW, Kontush A, Tall AR, Webb NR. 2016. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol 13(1):48-60. Russo MW, Hoofnagle JH, Gu J, Fontana RJ, Barnhart H, Kleiner DE, Chalasani N, Bonkovsky HL. 2014. Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network. Hepatology 60(2):679-86. Samstad EO, Niyonzima N, Nymo S, Aune MH, Ryan L, Bakke SS, Lappegård KT, Brekke OL, Lambris JD, Damås JK, Latz E, Mollnes TE, Espevik T. 2014. Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J Immunol 192(6):2837-45. Scanu A, Oliviero F, Luisetto R, Sfriso P, Dayer JM, Burger D, Punzi L. 2010. [HDL inhibit cytokine production in a mouse model of urate crystal-induced inflammation]. Reumatismo 62(4):266-72. Schmitz B, Vischer P, Brand E, Schmidt-Petersen K, Korb-Pap A, Guske K, Nedele J, Schelleckes M, Hillen J, Rötrige A, Simmet T, Paul M, Cambien F, Brand SM. 2013. Increased monocyte adhesion by endothelial expression of VCAM-1 missense variation in vitro. Atherosclerosis 230(2):185-90. Shaw JA, Bobik A, Murphy A, Kanellakis P, Blombery P, Mukhamedova N, Woollard K, Lyon S, Sviridov D, Dart AM. 2008. Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque. Circ Res 103(10):1084-91. Shridas P, De Beer MC, Webb NR. 2018. High-density lipoprotein inhibits serum amyloid A-mediated reactive-oxygen species generation and NLRP3 inflammasome activation. J Biol Chem Singh A, Neki NS, Bisht M, Choudhry S, Singh I, Gupta H. 2012. Current Advances in Understanding the Pathogenesis of Atherosclerosis and its Clinical Implications in Coronary Artery Disease. JIMSA251-253. Spirig R, Schaub A, Kropf A, Miescher S, Spycher MO, Rieben R. 2013. Reconstituted high-density lipoprotein modulates activation of human leukocytes. PLoS One 8(8):e71235. Stroncek DF, Fellowes V, Pham C, Khuu H, Fowler DH, Wood LV, Sabatino M. 2014. Counter-flow elutriation of clinical peripheral blood mononuclear cell concentrates for the production of dendritic and T cell therapies. J Transl Med 12:241. Stutz A, Golenbock DT, Latz E. 2009. Inflammasomes: too big to miss. J Clin Invest 119(12):3502-11. Suzuki M, Pritchard DK, Becker L, Hoofnagle AN, Tanimura N, Bammler TK, Beyer RP, Bumgarner R, Vaisar T, de Beer MC, de Beer FC, Miyake K, Oram JF, Heinecke JW. 2010. High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide. Circulation 122(19):1919-27. Tall AR, Yvan-Charvet L. 2015. Cholesterol, inflammation and innate immunity. Nat Rev Immunol 15(2):104-16. Thacker SG, Zarzour A, Chen Y, Alcicek MS, Freeman LA, Sviridov DO, Demosky SJ, Remaley AT. 2016. High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation. Immunology. Wadham C, Albanese N, Roberts J, Wang L, Bagley CJ, Gamble JR, Rye KA, Barter PJ, Vadas MA, Xia P. 2004. High-density lipoproteins neutralize C-reactive protein proinflammatory activity. Circulation 109(17):2116-22. Walker NJ. 2002. Tech.Sight. A technique whose time has come. Science 296(5567):557-9. Juan C Hernandez 38 Wang S, Liu D, Ning W, Xu A. 2015. Cytosolic dsDNA triggers apoptosis and pro inflammatory cytokine production in normal human melanocytes. Exp Dermatol 24(4):298-300. Westerterp M, Fotakis P, Ouimet M, Bochem AE, Zhang H, Molusky MM, Wang W, Abramowicz S, la Bastide-van Gemert S, Wang N, Welch CL, Reilly MP, Stroes ES, Moore KJ, Tall AR. 2018. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis and Atherogenesis. Circulation. Wurfel MM, Hailman E, Wright SD. 1995. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J Exp Med 181(5):1743-54. Yin Z, Deng T, Peterson LE, Yu R, Lin J, Hamilton DJ, Reardon PR, Sherman V, Winnier GE, Zhan M, Lyon CJ, Wong ST, Hsueh WA. 2014. Transcriptome analysis of human adipocytes implicates the NOD-like receptor pathway in obesity-induced adipose inflammation. Mol Cell Endocrinol 394(1-2):80-7 Ylä-Herttuala S, Bentzon JF, Daemen M, Falk E, Garcia-Garcia HM, Herrmann J, Hoefer I, Jauhiainen S, Jukema JW, Krams R, Kwak BR, Marx N, Naruszewicz M, Newby A, Pasterkamp G, Serruys PW, Waltenberger J, Weber C, Tokgözoglu L, Biology EWGoAaV. 2013. Stabilization of atherosclerotic plaques: an update. Eur Heart J 34(42):3251-8. Zheng SC, Zhu XX, Xue Y, Zhang LH, Zou HJ, Qiu JH, Liu Q. 2015. Role of the NLRP3 inflammasome in the transient release of IL-1β induced by monosodium urate crystals in human fibroblast-like synoviocytes. J Inflamm (Lond) 12:30. |
| dc.rights.license.none.fl_str_mv |
Atribución |
| dc.rights.accessrights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.coar.none.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| rights_invalid_str_mv |
Atribución http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.extent.spa.fl_str_mv |
760-770 |
| dc.coverage.temporal.spa.fl_str_mv |
39 (12) |
| dc.publisher.spa.fl_str_mv |
Mary Ann Liebert, Inc., publishers Universidad Cooperativa de Colombia, Facultad de Ciencias de la Salud, Programa de Medicina, Medellín y Envigado, Colombia, 00000 |
| dc.publisher.program.spa.fl_str_mv |
Medicina |
| dc.publisher.place.spa.fl_str_mv |
Medellín |
| institution |
Universidad Cooperativa de Colombia |
| bitstream.url.fl_str_mv |
https://repository.ucc.edu.co/bitstreams/76345f81-1b48-4c20-9b44-d231167b272c/download https://repository.ucc.edu.co/bitstreams/dd446240-3dd1-4c62-a924-e10e0cea6742/download https://repository.ucc.edu.co/bitstreams/3ba8183e-e90a-4adc-98e8-c22fbaa452c6/download https://repository.ucc.edu.co/bitstreams/6a68ed0f-daef-4e9b-bd41-73d2f8247820/download |
| bitstream.checksum.fl_str_mv |
3bce4f7ab09dfc588f126e1e36e98a45 168fb302cace043d0a89c83f2c45df82 547f7f712ab518353d012bf600fecafe c80735464ad71328805b774d86e5bd4d |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional Universidad Cooperativa de Colombia |
| repository.mail.fl_str_mv |
bdigital@metabiblioteca.com |
| _version_ |
1814247295551537152 |
| spelling |
Taborda, Natalia AndreaBlanquiceth, YuranyUrcuqui Inchima, SilvioLatz, EickeHernández López, Juan Carlos39 (12)2020-11-27T00:59:20Z2020-11-27T00:59:20Z2019-12-0110.1089/jir.2019.0029https://hdl.handle.net/20.500.12494/28300Taborda, N. A., Blanquiceth, Y., Urcuqui-Inchima, S., Latz, E., y Hernandez, J. C. (2019). High-Density Lipoproteins Decrease Proinflammatory Activity and Modulate the Innate Immune Response. Journal of Interferon & Cytokine Research, 39 (12), 760-770. Recuperado de https://www.liebertpub.com/doi/abs/10.1089/jir.2019.0029Atherosclerosis, a chronic inflammatory disease of the arterial wall, is the leading cause of cardiac disorders and stroke. The onset and progression of these diseases are linked with the inflammatory response, especially NLRP3 inflammasome activation, inducing the production of proinflammatory cytokines, such as interleukin 1b (IL-1b). Because high-density lipoproteins (HDLs) have shown significant antiatherogenic and antiinflammatory properties, we evaluated their immunomodulatory activity in response to cholesterol crystals and other innate immune activators. Human primary monocyte-derived macrophages, THP-1 cells, and murine macrophages were stimulated to activate NLRP3 inflammasome and other pattern recognition receptors, in the presence or absence of HDL. Then, HDL immunomodulatory effects were evaluated through IL-1b and IL-6 production by enzyme-linked immunosorbent assay. Furthermore, in vivo HDL antiinflammatory effects were evaluated in a murine model of peritoneal inflammatory infiltration. HDLs have an immunomodulatory effect on different cellular models, including peripheral blood mononuclear cells, THP-1 cells, and murine macrophages, by affecting the activity of innate immunity sensors, such as Toll-like receptors (TLRs), dectin-1, and inflammasomes. HDL reduces the proinflammatory role of cholesterol crystals, nigericin, and other NLRP3 and AIM2 inflammasome agonists, and several TLR agonists, leading to a decreased production of IL-1b and IL-6. The results suggest that HDLs are highly important in the regulation of the innate immune response and may have a beneficial role in controlling diseases associated with the inflammatory response.Atherosclerosis, a chronic inflammatory disease of the arterial wall, is the leading cause of cardiac disorders and stroke. The onset and progression of these diseases are linked with the inflammatory response, especially NLRP3 inflammasome activation, inducing the production of proinflammatory cytokines, such as interleukin 1b (IL-1b). Because high-density lipoproteins (HDLs) have shown significant antiatherogenic and antiinflammatory properties, we evaluated their immunomodulatory activity in response to cholesterol crystals and other innate immune activators. Human primary monocyte-derived macrophages, THP-1 cells, and murine macrophages were stimulated to activate NLRP3 inflammasome and other pattern recognition receptors, in the presence or absence of HDL. Then, HDL immunomodulatory effects were evaluated through IL-1b and IL-6 production by enzyme-linked immunosorbent assay. Furthermore, in vivo HDL antiinflammatory effects were evaluated in a murine model of peritoneal inflammatory infiltration. HDLs have an immunomodulatory effect on different cellular models, including peripheral blood mononuclear cells, THP-1 cells, and murine macrophages, by affecting the activity of innate immunity sensors, such as Toll-like receptors (TLRs), dectin-1, and inflammasomes. HDL reduces the proinflammatory role of cholesterol crystals, nigericin, and other NLRP3 and AIM2 inflammasome agonists, and several TLR agonists, leading to a decreased production of IL-1b and IL-6. The results suggest that HDLs are highly important in the regulation of the innate immune response and may have a beneficial role in controlling diseases associated with the inflammatory response.https://scienti.colciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0000283088http://orcid.org/0000-0002-9200-5698https://scienti.colciencias.gov.co/gruplac/jsp/visualiza/visualizagr.jsp?nro=00000000011355juanc.hernandezl@campusucc.edu.cohttps://scholar.google.com/citations?user=fo79p5QAAAAJ&hl=es760-770Mary Ann Liebert, Inc., publishersUniversidad Cooperativa de Colombia, Facultad de Ciencias de la Salud, Programa de Medicina, Medellín y Envigado, Colombia, 00000MedicinaMedellínhttps://www.liebertpub.com/doi/abs/10.1089/jir.2019.0029Journal of Interferon & Cytokine ResearchBarrientos-Arenas E, Henao-García V, Giraldo DM, Cardona MM, Urcuqui Inchima S, Castaño JC, Hernández JC. 2018. [Modulation of high-density lipoprotein and cytokine IL-1β and IL-6 levels in patients with dengue]. Rev Peru Med Exp Salud Publica 35(1):15-24.Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V, Latz E. 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183(2):787-91Beckman JA, Creager MA. 2006. The nonlipid effects of statins on endothelial function. Trends Cardiovasc Med 16(5):156-62.Beckman JA, Creager MA. 2006. The nonlipid effects of statins on endothelial function. Trends Cardiovasc Med 16(5):156-62.Cao J, Xu Y, Li F, Shang L, Fan D, Yu H. 2018. Protein markers of dysfunctional HDL in scavenger receptor class B type I deficient mice. J Transl Med 16(1):155.Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ. 1995. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 15(11):1987-94.Cook DN, Pisetsky DS, Schwartz DA. 2004. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5(10):975-9Cuzzocrea S, Dugo L, Patel NS, Di Paola R, Cockerill GW, Genovese T, Thiemermann C. 2004. High-density lipoproteins reduce the intestinal damage associated with ischemia/reperfusion and colitis. Shock 21(4):342-51.Charles-Schoeman C, Gugiu GB, Ge H, Shahbazian A, Lee YY, Wang X, Furst DE, Ranganath VK, Maldonado M, Lee T, Reddy ST. 2018. Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritis. Atherosclerosis 275:107-114.Chinni SR, Yamamoto H, Dong Z, Sabbota A, Bonfil RD, Cher ML. 2008. CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone. Mol Cancer Res 6(3):446-57.de la Roche M, Hamilton C, Mortensen R, Jeyaprakash AA, Ghosh S, Anand PK. 2018. Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation. J Cell BiolDe Nardo D, Labzin LI, Kono H, Seki R, Schmidt SV, Beyer M, Xu D, Zimmer S, Lahrmann C, Schildberg FA, Vogelhuber J, Kraut M, Ulas T, Kerksiek A, Krebs W, Bode N, Grebe A, Fitzgerald ML, Hernandez NJ, Williams BR, Knolle P, Kneilling M, Röcken M, Lütjohann D, Wright SD, Schultze JL, Latz E. 2014. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat Immunol 15(2):152-60.Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nuñez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E. 2010. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464(7293):1357-61.Ebrahim S, Taylor FC, Brindle P. 2014. Statins for the primary prevention of cardiovascular disease. BMJ 348:g280Galbois A, Thabut D, Tazi KA, Rudler M, Mohammadi MS, Bonnefont-Rousselot D, Bennani H, Bezeaud A, Tellier Z, Guichard C, Coant N, Ogier-Denis E,Moreau R, Lebrec D. 2009. Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis. Hepatology 49(1):175-84.Gilchrist M, Thorsson V, Li B, Rust AG, Korb M, Roach JC, Kennedy K, Hai T, Bolouri H, Aderem A. 2006. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441(7090):173-8.Grebe A, Latz E. 2013. Cholesterol crystals and inflammation. Curr Rheumatol Rep 15(3):313.Guo H, Callaway JB, Ting JP. 2015. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med 21(7):677-87.Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E, Halle A, Korte M, Latz E, Golenbock DT. 2013. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493(7434):674-8.Hernandez J, Sirois C, Latz E. 2011. Activation and Regulation of the NLRP3 Inflammasome. In.The Inflammasomes, Springer Basel. pp 197-208.Hernandez JC, Latz E, Urcuqui-Inchima S. 2014. HIV-1 induces the first signal to activate the NLRP3 inflammasome in monocyte-derived macrophages. Intervirology 57(1):36-42.Hernandez JC, Urcuqui-Inchima S. 2012. Activación y regulación del inflamasoma NLRP3 en las enfermedades infecciosas. Iatreia380-390.Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9(8):847-56Hornung V, Latz E. 2010. Critical functions of priming and lysosomal damage for 632 NLRP3 activation. Eur J Immunol 40(3):620-3.Inoue M, Williams KL, Gunn MD, Shinohara ML. 2012. NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 109(26):10480- 5.Kankkunen P, Teirilä L, Rintahaka J, Alenius H, Wolff H, Matikainen S. 2010. (1,3)-beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages. J Immunol 184(11):6335-42.Kant S, Kumar A, Singh SM. 2013. Myelopoietic efficacy of orlistat in murine hosts bearing T cell lymphoma: implication in macrophage differentiation and activation. PLoS One 8(12):e82396.Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11(5):373-84.Kitchens RL, Wolfbauer G, Albers JJ, Munford RS. 1999. Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J Biol Chem 274(48):34116-22.Latz E, Xiao TS, Stutz A. 2013. Activation and regulation of the inflammasomes. Nat Rev Immunol 13(6):397-411.Lawrence T, Gilroy DW. 2007. Chronic inflammation: a failure of resolution? Int J Exp Pathol 88(2):85-94.Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL. 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci U S A 90(24):12040-4.Li WL, Hua LG, Qu P, Yan WH, Ming C, Jun YD, Yuan LD, Nan N. 2016. NLRP3 inflammasome: a novel link between lipoproteins and atherosclerosis. Arch Med Sci 12(5):950-958.Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440(7081):228- 32.Marín-Palma D, Castro GA, Cardona-Arias JA, Urcuqui-Inchima S, Hernandez JC. 2018. Lower High-Density Lipoproteins Levels During Human Immunodeficiency Virus Type 1 Infection Are Associated With Increased Inflammatory Markers and Disease Progression. Front Immunol 9:1350.Martinon F, Gaide O, Pétrilli V, Mayor A, Tschopp J. 2007. NALP inflammasomes: a central role in innate immunity. Semin Immunopathol 29(3):213-29Martinon F, Mayor A, Tschopp J. 2009. The inflammasomes: guardians of the 669 body. Annu Rev Immunol 27:229-65.McDonald MC, Dhadly P, Cockerill GW, Cuzzocrea S, Mota-Filipe H, Hinds CJ, Miller NE, Thiemermann C. 2003. Reconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shock. Shock 20(6):551-7.McGeough MD, Pena CA, Mueller JL, Pociask DA, Broderick L, Hoffman HM, Brydges SD. 2012. Cutting edge: IL-6 is a marker of inflammation with no direct role in inflammasome-mediated mouse models. J Immunol 189(6):2707-11.McGrath KC, Li XH, Puranik R, Liong EC, Tan JT, Dy VM, DiBartolo BA, Barter PJ, Rye KA, Heather AK. 2009. Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol 29(6):877- 82.Miljkovic M, Stefanovic A, Simic-Ogrizovic S, Vekic J, Bogavac-Stanojevic N, Cerne D, Kocbek P, Marc J, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Kotur-Stevuljevic J. 2018. Association of Dyslipidemia, Oxidative Stress, Juan C Hernandez 35 and Inflammation With Redox Status in VLDL, LDL, and HDL Lipoproteins in Patients With Renal Disease. Angiology:3319718780041.Mineo C, Yuhanna IS, Quon MJ, Shaul PW. 2003. High density lipoprotein induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem 278(11):9142-9.Muñoz-Planillo R, Kuffa P, Martínez-Colón G, Smith BL, Rajendiran TM, Núñez G. 2013. K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38(6):1142- 53.Niyonzima N, Samstad EO, Aune MH, Ryan L, Bakke SS, Rokstad AM, Wrigh SD, Damås JK, Mollnes TE, Latz E, Espevik T. 2015. Reconstituted High Density Lipoprotein Attenuates Cholesterol Crystal-Induced Inflammatory Responses by Reducing Complement Activation. J Immunol 195(1):257- 64.Norata GD, Pirillo A, Ammirati E, Catapano AL. 2012. Emerging role of high density lipoproteins as a player in the immune system. Atherosclerosis 220(1):11-21.Park SH, Park JH, Kang JS, Kang YH. 2003. Involvement of transcription factors in plasma HDL protection against TNF-alpha-induced vascular cell adhesion molecule-1 expression. Int J Biochem Cell Biol 35(2):168-82Peeters PM, Eurlings IM, Perkins TN, Wouters EF, Schins RP, Borm PJ, Drommer W, Reynaert NL, Albrecht C. 2014. Silica-induced NLRP3 inflammasome activation in vitro and in rat lungs. Part Fibre Toxicol 11:58.Peshavariya H, Dusting GJ, Di Bartolo B, Rye KA, Barter PJ, Jiang F. 2009. Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts. Free Radic Res 43(8):772-82.Rajamäki K, Lappalainen J, Oörni K, Välimäki E, Matikainen S, Kovanen PT, Eklund KK. 2010. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One 5(7):e11765.Riwanto M, Rohrer L, Roschitzki B, Besler C, Mocharla P, Mueller M, Perisa D, Heinrich K, Altwegg L, von Eckardstein A, Lüscher TF, Landmesser U. 2013. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of Juan C Hernandez 36 high-density lipoprotein-proteome remodeling. Circulation 127(8):891- 904.Robbesyn F, Garcia V, Auge N, Vieira O, Frisach MF, Salvayre R, Negre Salvayre A. 2003. HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells. FASEB J 17(6):743-5.Robbins GR, Wen H, Ting JP. 2014. Inflammasomes and metabolic disorders: old genes in modern diseases. Mol Cell 54(2):297-308.Roberson SM, Walker WS. 1988. Immortalization of cloned mouse splenic macrophages with a retrovirus containing the v-raf/mil and v-myc oncogenes. Cell Immunol 116(2):341-51.Rosenson RS, Brewer HB, Ansell BJ, Barter P, Chapman MJ, Heinecke JW, Kontush A, Tall AR, Webb NR. 2016. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol 13(1):48-60.Russo MW, Hoofnagle JH, Gu J, Fontana RJ, Barnhart H, Kleiner DE, Chalasani N, Bonkovsky HL. 2014. Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network. Hepatology 60(2):679-86.Samstad EO, Niyonzima N, Nymo S, Aune MH, Ryan L, Bakke SS, Lappegård KT, Brekke OL, Lambris JD, Damås JK, Latz E, Mollnes TE, Espevik T. 2014. Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J Immunol 192(6):2837-45.Scanu A, Oliviero F, Luisetto R, Sfriso P, Dayer JM, Burger D, Punzi L. 2010. [HDL inhibit cytokine production in a mouse model of urate crystal-induced inflammation]. Reumatismo 62(4):266-72.Schmitz B, Vischer P, Brand E, Schmidt-Petersen K, Korb-Pap A, Guske K, Nedele J, Schelleckes M, Hillen J, Rötrige A, Simmet T, Paul M, Cambien F, Brand SM. 2013. Increased monocyte adhesion by endothelial expression of VCAM-1 missense variation in vitro. Atherosclerosis 230(2):185-90.Shaw JA, Bobik A, Murphy A, Kanellakis P, Blombery P, Mukhamedova N, Woollard K, Lyon S, Sviridov D, Dart AM. 2008. Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque. Circ Res 103(10):1084-91.Shridas P, De Beer MC, Webb NR. 2018. High-density lipoprotein inhibits serum amyloid A-mediated reactive-oxygen species generation and NLRP3 inflammasome activation. J Biol ChemSingh A, Neki NS, Bisht M, Choudhry S, Singh I, Gupta H. 2012. Current Advances in Understanding the Pathogenesis of Atherosclerosis and its Clinical Implications in Coronary Artery Disease. JIMSA251-253.Spirig R, Schaub A, Kropf A, Miescher S, Spycher MO, Rieben R. 2013. Reconstituted high-density lipoprotein modulates activation of human leukocytes. PLoS One 8(8):e71235.Stroncek DF, Fellowes V, Pham C, Khuu H, Fowler DH, Wood LV, Sabatino M. 2014. Counter-flow elutriation of clinical peripheral blood mononuclear cell concentrates for the production of dendritic and T cell therapies. J Transl Med 12:241.Stutz A, Golenbock DT, Latz E. 2009. Inflammasomes: too big to miss. J Clin Invest 119(12):3502-11.Suzuki M, Pritchard DK, Becker L, Hoofnagle AN, Tanimura N, Bammler TK, Beyer RP, Bumgarner R, Vaisar T, de Beer MC, de Beer FC, Miyake K, Oram JF, Heinecke JW. 2010. High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide. Circulation 122(19):1919-27.Tall AR, Yvan-Charvet L. 2015. Cholesterol, inflammation and innate immunity. Nat Rev Immunol 15(2):104-16.Thacker SG, Zarzour A, Chen Y, Alcicek MS, Freeman LA, Sviridov DO, Demosky SJ, Remaley AT. 2016. High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation. Immunology.Wadham C, Albanese N, Roberts J, Wang L, Bagley CJ, Gamble JR, Rye KA, Barter PJ, Vadas MA, Xia P. 2004. High-density lipoproteins neutralize C-reactive protein proinflammatory activity. Circulation 109(17):2116-22.Walker NJ. 2002. Tech.Sight. A technique whose time has come. Science 296(5567):557-9. Juan C Hernandez 38 Wang S, Liu D, Ning W, Xu A. 2015. Cytosolic dsDNA triggers apoptosis and pro inflammatory cytokine production in normal human melanocytes. Exp Dermatol 24(4):298-300.Westerterp M, Fotakis P, Ouimet M, Bochem AE, Zhang H, Molusky MM, Wang W, Abramowicz S, la Bastide-van Gemert S, Wang N, Welch CL, Reilly MP, Stroes ES, Moore KJ, Tall AR. 2018. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis and Atherogenesis. Circulation.Wurfel MM, Hailman E, Wright SD. 1995. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J Exp Med 181(5):1743-54.Yin Z, Deng T, Peterson LE, Yu R, Lin J, Hamilton DJ, Reardon PR, Sherman V, Winnier GE, Zhan M, Lyon CJ, Wong ST, Hsueh WA. 2014. Transcriptome analysis of human adipocytes implicates the NOD-like receptor pathway in obesity-induced adipose inflammation. Mol Cell Endocrinol 394(1-2):80-7Ylä-Herttuala S, Bentzon JF, Daemen M, Falk E, Garcia-Garcia HM, Herrmann J, Hoefer I, Jauhiainen S, Jukema JW, Krams R, Kwak BR, Marx N, Naruszewicz M, Newby A, Pasterkamp G, Serruys PW, Waltenberger J, Weber C, Tokgözoglu L, Biology EWGoAaV. 2013. Stabilization of atherosclerotic plaques: an update. Eur Heart J 34(42):3251-8.Zheng SC, Zhu XX, Xue Y, Zhang LH, Zou HJ, Qiu JH, Liu Q. 2015. Role of the NLRP3 inflammasome in the transient release of IL-1β induced by monosodium urate crystals in human fibroblast-like synoviocytes. J Inflamm (Lond) 12:30.AtherosclerosisHigh-Density lipoproteins decrease proinflammatory activity and modulate the innate immune responseArtículohttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAtribucióninfo:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2PublicationLICENSElicense.txtlicense.txttext/plain; charset=utf-84334https://repository.ucc.edu.co/bitstreams/76345f81-1b48-4c20-9b44-d231167b272c/download3bce4f7ab09dfc588f126e1e36e98a45MD52ORIGINALPREPRINT.pdfPREPRINT.pdfArtículoapplication/pdf1656398https://repository.ucc.edu.co/bitstreams/dd446240-3dd1-4c62-a924-e10e0cea6742/download168fb302cace043d0a89c83f2c45df82MD51THUMBNAILPREPRINT.pdf.jpgPREPRINT.pdf.jpgGenerated Thumbnailimage/jpeg5232https://repository.ucc.edu.co/bitstreams/3ba8183e-e90a-4adc-98e8-c22fbaa452c6/download547f7f712ab518353d012bf600fecafeMD53TEXTPREPRINT.pdf.txtPREPRINT.pdf.txtExtracted texttext/plain58779https://repository.ucc.edu.co/bitstreams/6a68ed0f-daef-4e9b-bd41-73d2f8247820/downloadc80735464ad71328805b774d86e5bd4dMD5420.500.12494/28300oai:repository.ucc.edu.co:20.500.12494/283002024-08-10 22:40:43.17restrictedhttps://repository.ucc.edu.coRepositorio Institucional Universidad Cooperativa de Colombiabdigital@metabiblioteca.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 |